The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
Adderall, Ritalin and other stimulants prescribed for attention-deficit/hyperactivity disorder seem to work on brain areas ...
Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut ...
AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo (TYO: 4568) said their jointly developed breast cancer therapy ENHERTU has ...
“Gedatolisib plus Faslodex, with or without Ibrance, represents a potential new standard of care for patients with hormone ...
1d
These groundbreaking Alzheimer’s drugs slow brain decline by treating the actual cause of dementia
Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
SurvivorNet on MSN
Enhertu significantly cuts recurrence rates for women with high-risk HER2-positive breast cancer — the practice-changing DESTINY-Breast05 trial
For women with a specific type of breast cancer known as HER2-positive (HER2+), any residual (leftover) disease after primary ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
2d
Breast cancer drug boosts leukemia treatment: Unexpected duo shows promise in overcoming resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback